Catalent has launched a Quality, Product Development and Regulatory Affairs organisation, to help bring products to market more quickly. The firm has appointed Sharon Johnson, Senior Vice President, Global Quality & Regulatory Affairs to head it up.
“The overall goal of the Quality, Product Development and Regulatory Affairs organisation will be to drive excellence and reliability across all of the products that we make and deliver,” explained Johnson. “Our customer promise is not only to provide a reliable supply of their current, ongoing products, but to deliver new products with the same rigorous commitment to excellence. Bringing together these two functions into one team will tighten collaboration and the partnerships across the organization which are needed to bring more new, innovative and life-saving products to market quicker.”
Prior to assuming her new responsibilities, Ms. Johnson had served as Catalent’s Senior Vice President, Global Quality & Regulatory Affairs since 2009, having overseen the roll-out of Catalent’s Global Quality Management system to over 20 global sites. Ms. Johnson has thirty-plus years of experience in the pharmaceutical industry, including API and multiple dosages forms, from discovery and launch of NCEs and life cycle management. Prior to joining Catalent, Ms. Johnson served as Vice President of Quality for GE Healthcare’s Medical Diagnostic Division, having previously worked in roles of increasing responsibility for Baxter Healthcare and Sanofi Aventis.